+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Interleukin"

Rheumatoid Arthritis Drugs Global Market Report 2024 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Psoriasis Treatment: Global Strategic Business Report - Product Thumbnail Image

Psoriasis Treatment: Global Strategic Business Report

  • Report
  • April 2024
  • 193 Pages
  • Global
From
From
Glycomic Therapeutics Global Market Report 2024 - Product Thumbnail Image

Glycomic Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
GMP Cell Therapy Consumables Global Market Report 2024 - Product Thumbnail Image

GMP Cell Therapy Consumables Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Axial Spondyloarthritis (axSpA) Global Market Report 2024 - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Celiac Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Celiac Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 115 Pages
  • Global
From
Chronic Idiopathic Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Idiopathic Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Psoriasis vulgaris - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis vulgaris - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Moderate to Severe Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate to Severe Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Crohns Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Crohns Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 100 Pages
  • Global
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Still's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Still's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cryopyrin-Associated Periodic Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Cryopyrin-Associated Periodic Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Adult-Onset Still Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Adult-Onset Still Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Loading Indicator

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases. In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more